Global Generic and Biosimilar Pharmaceuticals - Industry Report

Global Generic and Biosimilar Pharmaceuticals - Industry Report

The analysis conducted in the Generic and Biosimilar Pharmaceuticals (Global) report is ideal for anyone wanting to

• Identify the market leaders
• Spot companies heading for failure
• Seek out the most attractive acquisition opportunities
• Analyse industry trends
• Benchmark their own financial performance

Using an exclusive methodology, a quick glance of this Generic and Biosimilar Pharmaceuticals (Global) report will tell you the companies that have a declining financial rating, and those that have shown good sales growth.

Each of the largest 153 companies is meticulously scrutinised in an individual assessment and analysed using the most up-to-date and current financial data.

Every business is examined on the following features:

• A graphical assessment and presentation of a company’s financial performance
• An independent financial valuation
• Acquisition attractiveness - outlining a firm's takeover attractiveness
• Four year assessment of the profit/loss and balance sheet
• A written summary highlighting key performance issues

Subsequently, you will receive a thorough 100-page market analysis highlighting the latest changes in the Generic and Biosimilar Pharmaceuticals (Global) market.

This section includes:

• Best Trading Partners
• Sales Growth Analysis
• Profit Analysis
• Market Size
• Rankings

You can utilise the findings within this report to assess the attractiveness of potential acquisitions, gain a better understanding of the market, and identify sound companies with whom to trade.